Guidelines : Transgender Health - Children & Young People
Detail
Condition :
Transgender Health - Children & Young People
Keywords :
gender dysphoria, gender reassignment, gender re-assignment, gender identity clinics, GICs, gender incongruence, sex change, transgender, gender variance, trans masculine, trans feminine, testosterone suppression, menstrual suppression, Tavistock, shared care, puberty blocker
BNF Codes :
Committee Recommendations
Date
Committee Name
Narrative
Traffic Light Status
05 June 2024
With the publication of the final Cass Report and new NHSE commissioning policies for children & young people, guidance for primary care prescribing for people who access Gender Identity Services has been updated. See document.
NHSE guidance on prescribing and dispensing restrictions on puberty blockers and gender affirming hormones is also available - see documents
N/A
Documents
Type
Document
Review Date
Guidelines (Local)
Supplementary documents (CCG specific documents)
No records returned.
Drugs
Below are listed drugs that are used to treat Transgender Health - Children & Young People.
- Estradiol (patch) Amber
- Estradiol valerate (tablets) Amber
- Goserelin Amber
- Leuprorelin acetate Amber
- Nafarelin Amber
- Testosterone (gel) Amber
- Testosterone (injection) Amber
- Triptorelin Amber